Estelle Autissier in New York, New York

Home New York New York

Estelle Autissier has Nurse Practitioner as her primary medical specialty. Their primary office is: 622 W 168th St in New York, New York.

They're a part of the: Trustees Of Columbia University In The City Of New York medical group which has around 1,916 members. You can call their office at 212-305-9876 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Missouri, Columbia School Of Medicine and graduated in 2017 (around 7 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Estelle Marie Autissier Office Phone and Directions

Estelle Autissier
Trustees Of Columbia University In The City Of New York
622 W 168th St
New York, New York 10032
212-305-9876

Patient Ratings
Please rate your experience with Estelle Autissier below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-305-9876

Enter a starting address:

Healthcare Info for Estelle Autissier

Medical School: University Of Missouri, Columbia School Of Medicine
Graduation Year: 2017
The Primary Medical Specialty for Estelle Autissier is listed as: Nurse Practitioner
Approximate Years of Experience: 7
PAC (PECOS ID)#: 9032542584
NPI #: 1326690819
NPI Created On: 07/15/2019
NPI Last Updated Listed as: 10/21/2019
Primary Taxonomy Code: 363LA2100X
License Number:
431506
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836349201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Iron Deficiency Anemia

Name of Drug #1: INJECTAFER

Open Associated Drug #1: 0517-0650-01

Payments Total: $121